AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017
May 18, 2017
30583_dirs_2017-05-17_c753a250-b0d7-4c0a-8f39-78bfabc873c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-04-28
Reporting Person: BAFFI ROBERT (EVP, Technical Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-28 | Common Stock | A | 302 | $70.304 | Acquired | 147793 | Direct |
| 2017-05-15 | Common Stock | F | 1566 | $91.50 | Disposed | 146227 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 31676 | Indirect |
Footnotes
F1: Represents shares acquired by the reporting person pursuant to issuer's Employee Stock Purchase Plan.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19